Filter
315
Text search:
Pfizer
Featured
Recommendations
41
New Publications
17
Language
Document type
No document type
79
Guidelines
73
Studies & Reports
64
Fact sheets
41
Manuals
16
Strategic & Response Plan
15
Resource Platforms
8
Situation Updates
5
Training Material
4
Videos
4
Infographics
3
Online Courses
3
Countries / Regions
Brazil
14
Russia
11
Germany
9
Argentina
9
Global
9
South Africa
8
Ukraine
7
Middle East and North Africa
7
Latin America and the Carribbean
7
Mozambique
6
India
5
Chile
5
Africa
5
Ecuador
4
Senegal
3
China
3
Colombia
3
East and Southern Africa
3
West and Central Africa
3
Western and Central Europe
3
Paraguay
3
Liberia
2
Nigeria
2
Uganda
2
Philippines
2
Kenya
2
Indonesia
2
Peru
2
El Salvador
2
Congo, Democratic Republic of
1
Guinea-Bissau
1
Ghana
1
Somalia
1
Nepal
1
South Sudan
1
Syria
1
Chad
1
Tanzania
1
Sudan
1
Benin
1
Angola
1
Yemen
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Eastern Europe
1
Congo-Brazzaville
1
Timor Leste/ East Timor
1
Iran
1
Kazakhstan
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
104
Clinical Guidelines
20
Women & Child Health
7
Public Health
6
Key Resources
4
Annual Report MEDBOX
1
Pharmacy & Technologies
1
Toolboxes
COVID-19
154
Mental Health
30
TB
16
HIV
15
NTDs
14
AMR
12
Refugee
8
NCDs
8
Global Health Education
6
Disability
4
Health Financing Toolbox
4
Rapid Response
3
Caregiver
3
Pharmacy
3
Ebola
1
Conflict
1
Zika
1
Planetary Health
1
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have hoarded vaccines, companies have also played a decisi
...
O SAGE aplica os princípios da medicina baseada em evidências e estabeleceu um processo metodológico completo para emitir ou atualizar recomendações. Especificamente para vacinas contra a COVID-19, uma descrição detalhada dos processos metodológicos pode ser encontrada no esquema de evidênc
...
Stand 1.12.2020
(Comirnaty® 10 мкг або 30 мкг виробництва BioNTech/Pfizer та Spikevax® виробництва Moderna);
Anamnese zur Schutzimpfung gegen COVID-19 (Corona Virus Disease 2019) (Grundimmunisierung und Auffrischimpfungen)
–
...
– (Comirnaty® 10 мкг або 30 мкг виробництва BioNTech/Pfizer та
AUFKLÄRUNGSMERKBLATT
Zur Schutzimpfung gegen COVID-19 (Corona Virus Disease 2019) (Grundimmunisierung und Auffrischimpfungen)
– mit mRNA-Impfstoffen –
...
The Antimicrobial Resistance Benchmark has evaluated for the second time how the most important players in the antibiotic market are addressing the rise of resistance and the global need for appropriate access to antibiotics. Although we can see progress — it’s hanging by a thread.
We have reac
...
Health workers involved in deployment and implementation of COVID-19 vaccination require vaccine-specific knowledge to ensure safe and efficient vaccine delivery. This training provides key information about COVID-19 vaccines through short instructional videos, vaccine explainers, job aids, topic br
...
Seit August 2021 empfiehlt die Ständige Impfkommission (STIKO) allen Kindern und Jugendlichen ab 12 Jahren die Corona-Schutzimpfung mit Comirnaty® von BioNTech/Pfizer. Seit Mitte Dezember können auch Kinder zwischen 5 und 11 Jahren mit dem darauf
...
La dosis de refuerzo está indicada una vez transcurridos los 4 meses (120 días) de la última dosis del esquema inicial y será con vacuna de plataforma ARNm: Pfizer-BioNTech pediátrica a partir de los 5 años o Moderna para uso pediátrico a par
...
La evidencia disponible a nivel internacional sobre el uso de un segundo refuerzo muestra una mayor duración de la respuesta inmune y una disminución de la internación y la mortalidad por COVID 19 en la población de adultos mayores y huéspedes inmunocomprometidos. Por otra parte, el personal de
...
Countries, partners, and donors are committed to
the global elimination of blinding trachoma by 2020.
Achieving this public health milestone requires more
than funding; it requires health personnel with the
right mix of skills, and well supported and managed
health systems. Mass drug administra
...
Vaccines
recommended
COVID Reference 23 May 2021
Vacunas
recommended
COVID Reference 23 May 2021
L’ensemble du personnel de santé qui participe au déploiement et à la mise en œuvre de la vaccination contre la COVID-19 doit avoir les connaissances et les compétences requises pour garantir une administration sûre et efficace du vaccin contre la COVID-19. Ce cours de formation fournit des
...
يحتاج العاملون الصحيون الذين يشاركون في نشر وتنفيذ التطعيم ضد كوفيد-19 إلى معرفة خاصة بكل لقاح لضمان تقديم اللقاحات بشكل آمن وفعال. يوفر هذا التدريب معلومات أساسية ح
...
Bisher hat die STIKO empfohlen, dass alle im Ausland mit einem nicht in der EU zugelassenen Impfstoff geimpften Personen eine erneute Impfserie mit einem in der EU zugelassenen Impfstoff erhalten sollen. Ziel der im Epidemiologischen Bulletin 13/2022 veröffentlichten aktualisierten COVID-19-Impfemp
...
В настоящем отчете (это уже четвертое его издание) анализируются препятствия и факторы, затрудняющие доступ к препаратам для лечения лекарственно-устойчивого туб
...
